Fertility Blog

At a Glance → Illume Fertility has been named a 2026 LGBTQ+ Healthcare Equality Leader by the Human Rights Campaign Foundation, the eighth consecutive year earning the designation. → Only 255 of 741 participating healthcare facilities are publicly listed as Leaders in this year's directory, a notable drop from prior years given current legal and political pressures. → The recognition arrives during a year of significant pressure on LGBTQ+ healthcare access, making publicly identifiable inclusive providers harder to find and more important to patients. → For LGBTQ+ intended parents, inclusive care goes beyond welcoming language: it means a clinical team that understands donor conception, reciprocal IVF, gestational surrogacy, and the legal and financial landscape that comes with each path. The Human Rights Campaign Foundation (HRC) released its 2026 Healthcare Equality Index on June 5, 2026, and Illume Fertility has been named a Leader for the eighth year in a row. This year's report arrives in a healthcare landscape where LGBTQ+ care access is being actively debated and, in many states, restricted, which shaped both how facilities participated and how their results are being shared publicly.

At a glance → A coalition of 56 patient and professional organizations announced on May 12, 2026 that polycystic ovary syndrome will now be called polyendocrine metabolic ovarian syndrome, abbreviated PMOS → The decision followed a 14-year consensus process led by researchers at Monash University, with input from more than 22,000 patients and health professionals across six continents → Adoption will be gradual, with both names appearing in medical records, lab reports, and patient materials until PMOS becomes the standard term → Diagnostic criteria and treatment protocols are not affected by the renaming; fertility care for PMOS uses the same clinical approach as PCOS care In this article, you will find a plain-language breakdown of the PCOS name change, why your diagnosis and care will stay the same, and what the shift could mean for fertility treatment and research, from a reproductive endocrinologist who specializes in the condition.

Illume Fertility is proud to share that eight of our physicians have been named to Castle Connolly’s 2026 America’s Top Doctors® list, an annual honor that recognizes the top 7% of all physicians nationwide through a peer-nominated selection process.

The U.S. Supreme Court's 2022 decision to overturn Roe v. Wade directly impacted access to abortion care, but has also had concerning implications for IVF. Even states with stronger protections for reproductive healthcare have felt the ripple effects of this decision, including an increased demand for IVF treatment and legal uncertainty for providers.

Along with our new name, we're excited to introduce you to our new website! We've redesigned the site to be more accessible, convenient and user-friendly, so you can easily find all the information you need to help you navigate your fertility journey. Let's take a virtual tour together!

We are proud to share that Illume Fertility's physicians have been honored as Castle Connolly's 2025 America's Top Doctors, continuing a long history of the annual recognition.

We are happy to share that Illume Fertility's physicians have been honored as 2024 Castle Connolly America's Top Doctors, continuing a long history of the annual recognition.

Meet Dr. Barry Witt, the latest addition to Illume Fertility's physician team, and learn how his 30-year career as a board-certified reproductive endocrinologist will allow the practice serve even more patients.